A drug called ribociclib, currently used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer, a new study has ...

We may earn a commission from links on this page.

They once built a fort out of keyboards. We’ve updated this guide with a new model in the Other good laptops under $500 section. Lots of laptops cost less than $500, but it’s hard to find a ...

The S&P 500 has typically performed well in the last four months of years with solid gains in the first eight months. The index has also delivered modest gains in the last four months of U.S ...

At the end of August last year, the S&P 500 was up 17%. Fast-forward to 2024, and the index is up nearly 19%. As they say in New Orleans, "Laissez les bons temps rouler" -- let the good times roll.

The S&P 500 earnings yield fell to 4.60% from last week's 4.61%. The S&P EY has ended each week between 4.60% and 4.87% all quarter. It could have been Wilfred Frost, or it could have been another ...

This newest approval for amivantamab is the second approval in 6 months for the EGFR and MET bispecific antibody. Data from the MARIPOSA study (NCT04487080) support this newest approval, and ...

The S&P 500 (SPX), or Standard & Poor's 500, is a notable stock market index that measures the performance of 500 large companies listed on U.S. stock exchanges. The index was introduced in 1957 ...

Fig 2. Summary of guideline recommendations. AEs, adverse events; CDK4/6, cyclin-dependent kinase 4/6; ESR1, estrogen receptor 2; ER, estrogen receptor; ET, endocrine ...